Body mass index and psychiatric disorders: A Mendelian randomization study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hartwig, Fernando Pires ^a   Bowden, Jack ^b,c   Loret De Mola, Christian ^a   Tovo Rodrigues, Luciana ^a   Davey Smith, George ^b   Horta, Bernardo Lessa ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; BODY MASS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MAJOR DEPRESSION; MENDELIAN RANDOMIZATION ANALYSIS; OBESITY; ODDS RATIO; PROCEDURES; PSYCHOLOGY; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; BODY MASS INDEX; DEPRESSIVE DISORDER, MAJOR; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84987678191     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32730     Document Type: Article

References (50)

1. Swinburn, B. A. et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804-814 (2011).
2. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743-800 (2015).
3. Liem, E. T., Sauer, P. J., Oldehinkel, A. J. & Stolk, R. P. Association between depressive symptoms in childhood and adolescence and overweight in later life: review of the recent literature. Arch Pediatr Adolesc Med 162, 981-988 (2008).
4. Abou Abbas, L., Salameh, P., Nasser, W., Nasser, Z. & Godin, I. Obesity and symptoms of depression among adults in selected countries of the Middle East: A systematic review and meta-analysis. Clin Obes 5, 2-11 (2015).
5. Baskaran, A., Cha, D. S., Powell, A. M., Jalil, D. & McIntyre, R. S. Sex differences in rates of obesity in bipolar disorder: postulated mechanisms. Bipolar Disord 16, 83-92 (2014).
6. McElroy, S. L. & Keck, P. E. Jr. Obesity in bipolar disorder: An overview. Curr Psychiatry Rep 14, 650-658 (2012).
7. Limosin, F., Gasquet, I., Leguay, D., Azorin, J. M. & Rouillon, F. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia. Acta Psychiatr Scand 118, 19-25 (2008).
8. Saarni, S. E. et al. Body composition in psychotic disorders: A general population survey. Psychol Med 39, 801-810 (2009).
9. Citrome, L. & Vreeland, B. Schizophrenia, obesity, and antipsychotic medications: what can we do Postgrad Med 120, 18-33 (2008).
10. Wildes, J. E., Marcus, M. D. & Fagiolini, A. Obesity in patients with bipolar disorder: A biopsychosocial-behavioral model. J Clin Psychiatry 67, 904-915 (2006).
11. Vancampfort, D. et al. Relationships between obesity, functional exercise capacity, physical activity participation and physical selfperception in people with schizophrenia. Acta Psychiatr Scand 123, 423-430 (2011).
12. Luppino, F. S. et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67, 220-229 (2010).
13. Daly, M. The relationship of C-reactive protein to obesity-related depressive symptoms: A longitudinal study. Obesity (Silver Spring) 21, 248-250 (2013).
14. Liu, C. S., Carvalho, A. F., Mansur, R. B. & McIntyre, R. S. Obesity and bipolar disorder: synergistic neurotoxic effects Adv Ther 30, 987-1006 (2013).
15. Thakore, J. H., Mann, J. N., Vlahos, I., Martin, A. & Reznek, R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26, 137-141 (2002).
16. Ryan, M. C., Flanagan, S., Kinsella, U., Keeling, F. & Thakore, J. H. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci 74, 1999-2008 (2004).
17. Sengupta, S. et al. Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls Schizophr Res 102, 329-336 (2008).
18. Padmavati, R., McCreadie, R. G. & Tirupati, S. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia. Schizophr Res 121, 199-202 (2010).
19. Bjorngaard, J. H. et al. Association of Body Mass Index with Depression, Anxiety and Suicide-An Instrumental Variable Analysis of the HUNT Study. PLoS One 10, e0131708 (2015).
20. Phillips, A. N. & Davey Smith, G. How independent are "independent" effects Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol 44, 1223-1231 (1991).
21. Davey Smith, G. Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr 6, 27-43 (2011).
22. Davey Smith, G. et al. Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology. PLoS Med 4, e352 (2007).
23. Davey Smith, G. & Ebrahim, S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease Int J Epidemiol 32, 1-22 (2003).
24. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015).
25. Kivimaki, M. et al. Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesityassociated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004. Am J Epidemiol 173, 421-429 (2011).
26. Lawlor, D. A. et al. Using genetic loci to understand the relationship between adiposity and psychological distress: A Mendelian Randomization study in the Copenhagen General Population Study of 53, 221 adults. J Intern Med 269, 525-537 (2011).
27. Cronin, R. M. et al. Phenome-wide association studies demonstrating pleiotropy of genetic variants within FTO with and without adjustment for body mass index. Front Genet 5, 250 (2014).
28. Huang, H. & Tao, Y. X. Pleiotropic functions of the transmembrane domain 6 of human melanocortin-4 receptor. J Mol Endocrinol 49, 237-248 (2012).
29. Walter, S. et al. Revisiting Mendelian randomization studies of the effect of body mass index on depression. Am J Med Genet B Neuropsychiatr Genet 168B, 108-115 (2015).
30. Glymour, M. M., Tchetgen Tchetgen, E. J. & Robins, J. M. Credible Mendelian randomization studies: Approaches for evaluating the instrumental variable assumptions. Am J Epidemiol 175, 332-339 (2012).
31. Jokela, M. et al. Body mass index and depressive symptoms: instrumental-variables regression with genetic risk score. Genes, brain, and behavior 11, 942-948 (2012).
32. Hung, C. F. et al. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. The British journal of psychiatry: The journal of mental science 205, 24-28 (2014).
33. Pierce, B. L. & Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178, 1177-1184 (2013).
34. Hartwig, F. P. & Davies, N. M. Why internal weights should be avoided (not only) in MR-Egger regression. Int J Epidemiol In press (2016).
35. Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37, 658-665 (2013).
36. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44, 512-525 (2015).
37. Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol 40, 304-314 (2016).
38. Bowden, J. et al. Asessing the validity of MR-Egger regression for two-sample Mendelian randomization: The role of the I2 statistic. Int J Epidemiol In press (2016).
39. Martin, J. et al. Association of Genetic Risk for Schizophrenia With Nonparticipation Over Time in a Population-Based Cohort Study. Am J Epidemiol 183, 1149-1158 (2016).
40. Lopresti, A. L. & Drummond, P. D. Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuropsychopharmacol Biol Psychiatry 45, 92-99 (2013).
41. Khandaker, G. M. et al. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2, 258-270 (2015).
42. Wium-Andersen, M. K., Orsted, D. D. & Nordestgaard, B. G. Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: A mendelian randomization study. Biol Psychiatry 76, 249-257 (2014).
43. Herman, M. A. & Rosen, E. D. Making Biological Sense of GWAS Data: Lessons from the FTO Locus. Cell Metab 22, 538-539 (2015).
44. Psychiatric G. W. A. S. Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43, 977-983 (2011).
45. Ripke, S. et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18, 497-511 (2013).
46. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
47. Province, M. A. & Borecki, I. B. A correlated meta-analysis strategy for data mining "OMIC" scans. Pac Symp Biocomput, 236-246 (2013).
48. Corbin, L. J. et al. Body mass index as a modifiable risk factor for type 2 diabetes: Refining and understanding causal estimates using Mendelian randomisation. Diabetes (2016).
49. Greco, M. F., Minelli, C., Sheehan, N. A. & Thompson, J. R. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34, 2926-2940 (2015).
50. Thomas, D. C., Lawlor, D. A. & Thompson, J. R. Re: Estimation of bias in nongenetic observational studies using "Mendelian triangulation" by Bautista et al. Ann Epidemiol 17, 511-513 (2007).